PTX3 and AIDS: These molecules have also been found to be increased in patients with other infectious or chronical diseases such as sepsis, HIV-1-AIDS, tuberculosis, rheumatoid-arthritis and various cancers with suPAR, sEPCR and PTX3, often predicting poor clinical outcomes as in our present study [8,14,15,16].